Also, phytochemicals could specifically inhibit in silico, viral protein nsp5 -encoded main protease (M pro ), the autocleavage enzyme critical for COVID-19 pathogenesis 768
Citation: ClinicalTrials.gov
A.HasanF.HameedA.AhmedS
From the viewpoint of neurotransmitters and neurotransmission for the brain, cerebral, cerebellar, hypothalamus, and hippocampus lesions, and cytoprotection as innate background for the interconnected pleiotropic beneficial effect, there is growing evidence that BPC 157 therapy can counteract the occlusion/occlusion-like syndromes [40,41,42,43,47,48,49,50,51,52,53,54,55,56]
J Appl Physiol 110:774780 Clinicaltrials.gov